Cell stress activates γ9δ2 T cells via endogenous phosphoantigens and butyrophilin complex dynamics - 04/02/26

Abstract |
Phosphoantigens (pAgs) are phosphate-containing small molecules that elicit an immune response. The pAgs bind to the intracellular domain of butyrophilin 3 (BTN3), enabling interactions with other butyrophilins to form complexes that trigger the T cell receptor (TCR) of Vγ9Vδ2 (γ9δ2) T cells. Despite multiple reports on this process, the conditions that regulate pAg levels leading to their detection remain unclear. Here we reveal a novel stress detection pathway, a type of lymphoid stress-surveillance response, in which mild cold stress triggers endogenous pAgs to engage with BTN family proteins, leading to the activation of γ9δ2 T cells. This stress response is dependent upon endogenous pAgs, as inhibition of HMG-CoA reductase abrogates the effect. It is also dependent upon BTN proteins, as depletion of BTN3A1 reduces the response. The ability of BTN2A1/BTN3A1 to respond is enhanced by the presence of BTN3A2 or BTN3A3. Furthermore, the internal domains of BTN2A1, BTN3A1, and BTN3A3 display differing abilities to dimerize, with BTN2A1 a constitutive dimer, BTN3A1 a monomer, and BTN3A3 a concentration dependent dimer. Full length BTN2A1/3A1 hybrid proteins additionally reveal that appropriately spaced multimers of BTN2A1 and BTN3A1 are critical in engaging the γ9δ2 TCR. In summary, our study uncovers a novel γ9δ2 T cell activation pathway mediated by cell stress and mevalonate pathway intermediates and highlights the critical roles of the BTN family members and their spacing in this process.
Le texte complet de cet article est disponible en PDF.Graphical Abstract |
Highlights |
• | BTN proteins detect cold stress to activate γ9δ2 T cells. |
• | γ9δ2 T cell cold stress activation is dependent on mevalonate pathway. |
• | The complete unit for γ9δ2 T cell activation is BTN2A1 +BTN3A1 +BTN3A2 +BTN3A3. |
• | BTN2A1/3A1 hybrid proteins can replace BTN2A1 to activate γ9δ2 T cells. |
Keywords : Antigens, B30.2-SPRY Domain, T cell receptor, Gamma-delta, Butyrophilins, Mevalonate pathway
Plan
Vol 195
Article 119023- février 2026 Retour au numéroBienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?
